| Literature DB >> 22393273 |
Jianhong An1, Edward Hsi, Xiangtian Zhou, Yijin Tao, Suh-Hang Hank Juo, Chung-Ling Liang.
Abstract
PURPOSE: Fibroblast growth factor-2 (FGF2) has been implied in the development of myopia according to previous studies investigating FGF2 in the sclera and retinal pigment epithelium. This study measured retinal FGF2 gene expression in an animal model and also tested for the association between single nucleotide polymorphisms (SNPs) in FGF2 and high myopia.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22393273 PMCID: PMC3291517
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
The kit assay ID for each SNP.
| C__27486143_10 | C__27486143_10_F | C__27486143_10_R | |
| C___8837778_10 | C___8837778_10_F | C___8837778_10_R | |
| C____802937_10 | C____802937_10_F | C____802937_10_R | |
| C____802931_10 | C____802931_10_F | C____802931_10_R | |
| C____802929_20 | C____802929_20_F | C____802929_20_R | |
| C__34186735_10 | C__34186735_10_F | C__34186735_10_R |
Refraction and axial length (AL) data measured in the beginning and end of the experiments in the three types of eyes.
| 0 | Mean±SD | 6.14± 1.15 | 6.44±1.02 | 6.51±0.98 | 6.34±1.05 | 7.81±0.11 | 7.81±0.11 | 7.87±0.11 | 7.87±0.11 |
| | p | 0.57 | 0.06 | 0.95 | 0.89 | ||||
| 2 | Mean±SD | 1.82±2.33 | 7.29±0.77 | 6.03±0.90 | 6.08±0.92 | 8.18±0.17 | 8.02±0.11 | 8.11±0.13 | 8.12±0.14 |
| p | <0.001 | 0.77 | <0.001 | 0.52 | |||||
FD: form deprivation; FDM: form deprivation myopia. P values are the comparison between the two eyes of a same animal using the paired t-test.
The length of each eye component. The data are presented as mean±SD.
| | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | ||||||||||||
| Wk 0 | 1.01±0.04 | 1.02±0.04 | 1.04±0.04 | 1.03±0.04 | 3.71±0.08 | 3.69±0.07 | 3.72±0.07 | 3.72±0.08 | 3.10±0.07 | 3.10±0.06 | 3.12±0.08 | 3.12±0.08 |
| p value | 0.10 | 0.15 | 0.07 | 0.46 | 0.84 | 0.13 | ||||||
| Wk 2 | 1.05±0.03 | 1.04±0.04 | 1.05±0.04 | 1.05±0.04 | 3.88±0.07 | 3.89±0.07 | 3.90±0.10 | 3.89±0.10 | 3.23±0.13 | 3.09±0.06 | 3.16±0.11 | 3.16±0.09 |
| p value | 0.22 | 0.37 | 0.38 | 0.30 | <0.001 | 0.80 | ||||||
FD: form deprivation; FDM: form deprivation myopia. P values are the comparison between the two eyes of a same animal using the paired t-test.
Figure 1Relative FGF2 mRNA level in FDM, fellow and normal eyes. The expression levels of FDM eye (n=14) and fellow eye (n=14) were significantly higher than normal eye (n=13, the averaged data from both eyes was used for each animal; p=0.00004 and 0.0027, respectively). The expression level of FDM eye was also higher than the fellow eye (p=0.0334). The expression level of normal eye was the expression level of right (n=13) eyes of normal control guinea pigs. The test of significance in comparing FDM and fellow eyes was using paired-t statistics, and unpaired t-test for the comparison between eyes of normal controls and eyes of form deprivation group.
The association between tSNPs and their relationships to high myopia (refraction in case ≤-6 D; in control ≥-1.5D).
| Case | 642 (64.8%) | 317 (32.0%) | 31 (3.1%) | 19.1% | 0.2293 | |
| (T/A) | Control | 620 (63.7%) | 308 (31.7%) | 45 (4.6%) | 20.5% | |
| Case | 930 (88.6%) | 118 (11.2%) | 2 (0.2%) | 5.8% | 0.9119* | |
| (G/A) | Control | 877 (88.5%) | 111 (11.2%) | 3 (0.3%) | 5.9% | |
| Case | 348 (33.2%) | 516 (49.1%) | 186 (17.7%) | 42.3% | 0.6037 | |
| (A/T) | Control | 335 (33.8%) | 467 (47.1%) | 189 (19.1%) | 42.6% | |
| Case | 991 (92.3%) | 81 (7.6%) | 1 (0.1%) | 3.9% | 0.4931* | |
| (T/C) | Control | 940 (93.3%) | 65 (6.5%) | 2 (0.2%) | 3.4% | |
| Case | 260 (24.4%) | 532 (50.0%) | 272 (25.6%) | 50.6% | 0.2736 | |
| (C/T) | Control | 245 (24.5%) | 529 (52.8%) | 227 (22.7%) | 49.1% | |
| Case | 366 (34.8%) | 497 (47.3%) | 188 (17.9%) | 41.5% | 0.5546 | |
| (G/A) | Control | 360 (36.1%) | 477 (47.8%) | 161 (16.1%) | 40.0% |
P values were from 2×3 Tables (3 genotypes versus 2 phenotypes). *p-value is adjusted by fisher exact test; MAF: minor allele frequency.
Six tSNPs and their relationships to extreme myopia (refraction in case ≤-10 D; in control ≥-0.5D).
| Case | 76 (66.1%) | 35 (30.4%) | 4 (3.5%) | 18.7% | 0.7511* | |
| (T/A) | Control | 363 (62.7%) | 187 (32.3%) | 29 (5.0%) | 21.2% | |
| Case | 118 (92.2%) | 10 (7.8%) | 0 (0.0%) | 3.9% | 0.4028* | |
| (G/A) | Control | 520 (88.3%) | 68 (11.5%) | 1 (0.2%) | 5.9% | |
| Case | 35 (26.7%) | 77 (58.8%) | 19 (14.5%) | 43.9% | 0.0276 | |
| (A/T) | Control | 209 (35.4%) | 271 (45.9%) | 111 (18.8%) | 41.7% | |
| Case | 123 (93.9%) | 8 (6.1%) | 0 (0.0%) | 3.1% | 0.8645 | |
| (T/C) | Control | 560 (93.5%) | 39 (6.5%) | 0 (0.0%) | 3.3% | |
| Case | 28 (21.4%) | 72 (55.0%) | 31 (23.7%) | 51.1% | 0.784 | |
| (C/T) | Control | 144 (24.2%) | 314 (52.8%) | 137 (23.0%) | 49.4% | |
| Case | 47 (36.2%) | 64 (49.2%) | 19 (14.6%) | 39.2% | 0.9697 | |
| (G/A) | Control | 216 (36.4%) | 286 (48.2%) | 91 (15.4%) | 39.5% |
*p-value is adjusted by fisher exact test.